Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Polymerase Chain Reaction Market, by Product Type (Instrument (Real Time PCR, Digital PCR, and Others) Reagents, and Consumables) and by End User (Clinical Diagnostics, Academic and Research Laboratories, Forensic Laboratories, and Others) is estimated to be valued at US$ 3.7 billion in 2017 and is estimated to exhibit a CAGR of 8.8% over the forecast period (2017-2025).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1546
Polymerase chain reaction (PCR) is laboratory technique, which is utilized for amplifying a single copy or a few copies of DNA segment to create several thousand to millions of copies of a particular DNA sequence. Moreover, PCR finds its applications in various fields such as diagnosis of infectious diseases, which include middle ear infections, tuberculosis, Lyme disease, DNA fingerprinting, paternity testing. It is also utilized in various molecular research applications such as DNA sequencing, DNA cloning, and gene expression. Furthermore, increasing prevalence and rising incidence of infectious and chronic disease coupled with increasing need to develop advanced polymerase chain reaction system, in order to deliver rapid and inexpensive quantitative detection of target sample are the major factors that are expected to drive growth of global polymerase chain reaction market over the forecast period. In addition, Digital PCR (dPCR) is a new approach to nucleic acid detection and quantification.
Digital PCR offers ultrasensitive and absolute nucleic acid quantification. dPCR is mainly used for rare allele detection, coupled with absolute quantification of gene expression and viral load. Moreover, technological advancements in the dPCR has driven manufacturers to launch droplet digital PCR (ddPCR). Additionally, ddPCR is a method of performing digital PCR using water-oil emulsion droplet technology. In ddPCR technology sample is fractionated into 20,000 droplets, and PCR amplification of the template molecules is performed in each individual droplet, then by counting the positive droplets provides precise and absolute target quantification. ddPCR technology make use of reagents and workflows, similar to those used for most standard probe-based assays.
Browse 28 Market Data Tables and 34 Figures spread through 150 Pages and in-depth TOC on “Polymerase Chain Reaction Market, by Product Type (Instrument (Real Time PCR, Digital PCR, Others) Reagents and Consumables) and by End User (Clinical Diagnostics, Academic and Research Laboratories, Forensic Laboratories, and Others) – Global Forecast to 2025”
To know the latest trends and insights related to polymerase chain reaction market Press Release, click the link below: https://bit.ly/3cbDpeN
In addition, continuous research and development, coupled with technological advancements by key players in polymerase chain reaction system has resulted in the development of affordable instruments, reagents, and consumables in the field of clinical diagnosis. For instance, in March 2018, Sekisui Diagnostics launched Silaris Influenza A&B Test: an affordable, polymerase chain reaction (PCR) testing platform that is designed precisely for point-of-care (POC) infectious disease diagnosis. Moreover, in October 2017, Diatech Pharmacogenetics srl launched easyPGX, a ready to use in-vitro diagnostic real-time PCR product line and Helix, a polymerase chain reaction kit for the extraction of circulating free DNA from plasma.
Similarly, Bio-Rad Laboratories launched droplet digital PCR (ddPCR) Supermix for Residual DNA Quantification, in September 2015. The new supermix is designed to use with Bio-Rad’s Droplet Digital PCR Systems, and allows highly precise and sensitive method for DNA measurement. Additionally, in November 2014, Chai Biotechnologies Inc. launched Open qPCR, a real-time PCR Thermocycler. The new instrument is designed for genetic genotyping, pathogen detection, and relative DNA quantification. Moreover, Bio-Rad Laboratories launched Precision Blue Real-Time PCR Dye, in April 2014. Blue dye is compatible with Bio-Rad’s universal qPCR supermixes and can be used with all Bio-Rad’s CFx real time PCR systems. In November 2012, Life Technologies Corporation also launched its Applied Biosystems QuantStudio Dx Real-Time PCR Instrument, in Europe. This instrument is designed for clinical diagnostic laboratory tests such as pathogen detection, gene expression analysis, SNP genotyping, mutation detection, micro-RNA, and other non-coding RNA analysis.
Apply Promo Code “STAYHOME” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1546
Key takeaways of the polymerase chain reaction market:
- The global polymerase chain reaction market is expected to exhibit a CAGR of 8.8% over the forecast period (2017-2025). This is attributed to increasing prevalence of chronic and infectious disease, coupled with continuous technology advancements in polymerase chain reaction from lucrative markets such as Asia Pacific, Latin America, Middle East, and Africa.
- Among product type, reagents and consumables segment is expected to account for major market share over the forecast period, attributed to its inevitable need in PCR instruments to run sample and for amplifying the target DNA sequence.
- Among end user, academic and research laboratories segment is expected to account for largest market share, owing to rising need of polymerase chain reaction (PCR) system in advanced laboratory testing and research services
- Key players operating in the global polymerase chain reaction market include F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., bioMérieux, S.A., Enzo Life Science, Inc., Abbott Laboratories, Takara Bio Inc., Becton, Dickinson and Company, and Danaher Corporation, among others
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/1546
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027